This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2012 Jun 28;55(12):5676-703.

doi: 10.1021/jm300087j. Epub 2012 Apr 17.

Medicinal chemistry of A₃ adenosine receptor modulators: pharmacological activities and therapeutic implications

Pier Giovanni Baraldi¹, Delia Preti, Pier Andrea Borea, Katia Varani

Affiliations

PMID: 22468757
DOI: 10.1021/jm300087j

Review

Medicinal chemistry of A₃ adenosine receptor modulators: pharmacological activities and therapeutic implications

Pier Giovanni Baraldi et al. J Med Chem. 2012.

. 2012 Jun 28;55(12):5676-703.

doi: 10.1021/jm300087j. Epub 2012 Apr 17.

Authors

Pier Giovanni Baraldi¹, Delia Preti, Pier Andrea Borea, Katia Varani

Affiliation

¹ Dipartimento di Scienze Farmaceutiche, Università di Ferrara, 44121 Ferrara, Italy. baraldi@unife.it

PMID: 22468757
DOI: 10.1021/jm300087j

No abstract available

PubMed Disclaimer

Similar articles

Polypharmacology of N⁶-(3-Iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA) and Related A₃ Adenosine Receptor Ligands: Peroxisome Proliferator Activated Receptor (PPAR) γ Partial Agonist and PPARδ Antagonist Activity Suggests Their Antidiabetic Potential.
Yu J, Ahn S, Kim HJ, Lee M, Ahn S, Kim J, Jin SH, Lee E, Kim G, Cheong JH, Jacobson KA, Jeong LS, Noh M. Yu J, et al. J Med Chem. 2017 Sep 14;60(17):7459-7475. doi: 10.1021/acs.jmedchem.7b00805. Epub 2017 Aug 28. J Med Chem. 2017. PMID: 28799755 Free PMC article.
Topological sub-structural molecular design (TOPS-MODE): a useful tool to explore key fragments of human A3 adenosine receptor ligands.
Saíz-Urra L, Teijeira M, Rivero-Buceta V, Helguera AM, Celeiro M, Terán MC, Besada P, Borges F. Saíz-Urra L, et al. Mol Divers. 2016 Feb;20(1):55-76. doi: 10.1007/s11030-015-9617-z. Epub 2015 Jul 24. Mol Divers. 2016. PMID: 26205409
Current Status in the Design and Development of Agonists and Antagonists of Adenosine A3 Receptor as Potential Therapeutic Agents.
Mailavaram RP, Al-Attraqchi OHA, Kar S, Ghosh S. Mailavaram RP, et al. Curr Pharm Des. 2019;25(25):2772-2787. doi: 10.2174/1381612825666190716114056. Curr Pharm Des. 2019. PMID: 31333098 Review.
Receptor-driven identification of novel human A₃ adenosine receptor antagonists as potential therapeutic agents.
Paoletta S, Federico S, Spalluto G, Moro S. Paoletta S, et al. Methods Enzymol. 2010;485:225-44. doi: 10.1016/B978-0-12-381296-4.00013-0. Methods Enzymol. 2010. PMID: 21050920
Therapeutic potential of A2 and A3 adenosine receptor: a review of novel patented ligands.
Federico S, Spalluto G. Federico S, et al. Expert Opin Ther Pat. 2012 Apr;22(4):369-90. doi: 10.1517/13543776.2012.669375. Epub 2012 Mar 22. Expert Opin Ther Pat. 2012. PMID: 22435652 Review.

See all similar articles

Cited by

Discovery of benzothiazolylquinoline conjugates as novel human A₃ receptor antagonists: biological evaluations and molecular docking studies.
Sarkar B, Maiti S, Jadhav GR, Paira P. Sarkar B, et al. R Soc Open Sci. 2018 Feb 7;5(2):171622. doi: 10.1098/rsos.171622. eCollection 2018 Feb. R Soc Open Sci. 2018. PMID: 29515874 Free PMC article.
C2-linked alkynyl poly-ethylene glycol(PEG) adenosine conjugates as water-soluble adenosine receptor agonists.
Ferguson L, Madieh NS, Vaideanu A, Schatzlein A, Festa J, Singh H, Wells G, Bhakta S, Brucoli F. Ferguson L, et al. Chem Biol Drug Des. 2023 Feb;101(2):340-349. doi: 10.1111/cbdd.14128. Epub 2022 Aug 22. Chem Biol Drug Des. 2023. PMID: 35993496 Free PMC article.
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update.
IJzerman AP, Jacobson KA, Müller CE, Cronstein BN, Cunha RA. IJzerman AP, et al. Pharmacol Rev. 2022 Apr;74(2):340-372. doi: 10.1124/pharmrev.121.000445. Pharmacol Rev. 2022. PMID: 35302044 Free PMC article. Review.
Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases.
Effendi WI, Nagano T, Kobayashi K, Nishimura Y. Effendi WI, et al. Cells. 2020 Mar 24;9(3):785. doi: 10.3390/cells9030785. Cells. 2020. PMID: 32213945 Free PMC article. Review.
A_2A Adenosine Receptor Antagonists in Neurodegenerative Diseases.
Merighi S, Borea PA, Varani K, Vincenzi F, Jacobson KA, Gessi S. Merighi S, et al. Curr Med Chem. 2022;29(24):4138-4151. doi: 10.2174/0929867328666211129122550. Curr Med Chem. 2022. PMID: 34844537 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- American Chemical Society
Other Literature Sources
- The Lens - Patent Citations Database
Chemical Information
- BindingDB